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The disease in which Mutra is voided with much 
Dukha (difficulty) is called Mutrakrichhra.[1] The 
disease in which urine is passed with difficulty is called 
Mutrakrichhra. The description of   Mutrakrichhra is 
available in Atharvaveda. There are references 
regarding urogenital system in Atharvaveda. Urinary 
structures like Vrikka (kidneys), Vasti (urinary 
bladder), Mehana (urethra), Gavini (ureter) etc. are 
mentioned. 
Acharya Charaka has described  Mutraghata in 19th 
chapter of Sutrasthana but the detailed description of 
eight types of Mutrakrichhra have been  defined along  
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with its aetiopathogenesis and treatment in the 26th 
chapter of Chikitsasthana. 
The   Uttaratantra   of   Sushruta Samhita   contains   
description of 8 types Mutrakrichhra.[2] Astanga 
Sangraha and Astanga Hrudaya, both the Acharyas 
have classified the disease of Mutravaha Srotas 
according  to  its Pravrutti (frequency). Acharya 
Sharangdhara has described eight types of 
Mutrakrichhra and thirteen types of Mutraghata.[3] In 
the chapter 30 and 31 Acharya Madhavkara has given 
detailed description of Mutrakrichhra and 
Mutraghata. The description of Mutrakrichhra is 
available in almost every authentic texts of Ayurveda. 
Mutrakrichhra is considered as disease of Mutravaha 
Srotas (urinary system). So the present study has been 
planned to evaluate the action of Shigru[4] on E.Coli.[5] 
OBJECTIVES 
To evaluate the action of Shigru on E.coli and also 
study the complication if any occurs during the course 
of treatment. 
MATERIALS AND METHODS 
Criteria of selection of patient 
Inclusion Criteria 
The patients attending the O.P.D. and I.P.D. of 
Research Department of Govt. Ayurvedic Hospital, 
A B S T R A C T  
All the Acharyas have described the pathogenesis of Mutrakrichha and Vasti (bladder) Rogas. Acharya 
Charaka has given specific pathogenesis of Mutrakrichha, that  Doshas  being  provoked  by  their  
respective  aetiological factors, individually or altogether   reaches Vasti and Mutramarga and begins 
to compress on all sides and thus results in Mutrakrichha. The vitiated Doshas enter into Vasti, which 
is the place of Khavaigunya. Dosa Dushya Sammurchhana  takes  place and  Mutradusti occurs. 
Dushita Mutra causes irritation and spasm of urinary tract and leads to difficulty in micturition. 
Sushruta in general has explained the pathogenesis of Vasti Roga and Vayu as the main causative 
factor. Samyak Apana Vayu helps in proper excretion of urine from Vasti and when this Vayu becomes 
Pratiloma (opposite) produces disorders in Vasti.   
Key words: Mutrakrichhra, Vasti, E.coli, Mutraghata, Shigru, UTI. 
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Patna, having classical symptomatolgy of 
Mutrakricchra. Careful elucidation and evaluation of 
medical history of patients. The patients having 
classical symptomatology of Mutrakrichhra were 
enrolled. 
Detailed physical and clinical examination on the basis 
of proforma specially prepared for this purpose. The 
patient under 70 years irrespective of caste, religion, 
sex, habits, Socioeconomic status and those who fulfill 
the diagnosis were selected for the study. 
Exclusion Criteria 
Patients of diabetes, hypertension. Thyroid 
dysfunction, Carcinoma, Sexually transmitted 
diseases, Pregnant womon and other severe diseases 
laid down as per rules are excluded. 
Haematological Investigations 
The following laboratory investigation were under 
taken in each case just before beginning of drug trial 
and after completion of the study.  Blood - Hb%, TLC, 
DLC, ESR & PCV. Above mentioned all pathological 
investigation were done in hospital attached 
laboratory. 
Urine routine and culture  
Urine analysis for its colour, appearance, specific 
gravity, reaction etc. and urine culture is done to rule 
out microorganism. 
Radiological Investigations 
If required USG of urinary system (KUB) was done to 
rule out any pathological obstruction in urinary tract. 
Study design:  Single arm clinical study 
Patients were subjected to medicine with the drug 
under trial. 
▪ Drug - Shigru Ghana Vati 
▪ Dose - 500 mg BD 
▪ Route of administration - oral 
▪ Duration of therapy - 90 days 
Diet advised 
They were advised to follow the dietary restriction 
like; 
1. High intake of water 
2. Intake of plenty of fluid in the form of soups, 
coconut water, juices and glucose water. 
3. Maintenance of perineal hygiene. 
4. Not to suppress the urge of micturation. 
5. Complete and frequent emptying of the bladder 
at short intervals. 
Routine laboratory investigation and sign and 
symptoms scoring have  been carried out before and 
after treatment. 
The drug efficacy was assessed on the basis of clinical 
observation in course of the treatment, especially the 
sign and symptoms beside the laboratory 
investigation before and after the course of 
treatment. 
Criteria for assessment 
1. Cured : This was decided on the basis of following 
two points. Complete relief in the initial chief 
complaints of the patient along with the positive 
improvement (100% relief in signs and 
symptoms). Complete no growth of organism in 
urine culture examination. 
2. Moderately improvement : 30-59% relief in sign 
and symptoms.  
3. Mild improvement : below - 30% relief in sign and 
symptoms 
4. Unchanged - No relief : This was the group of 
patients in our series which did not report either 
symptomatic relief in their basic complain and not 






 Highly Significant P<0.001 
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OBSERVATIONS AND RESULTS 
Table 1: Effect of Shigru Ghana on clinical symptoms 
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For the burning micturation there was 70.51% relief 
with p<0.001 that was highly significant. In the 
frequent micturation there was 62.84% relief with 
p<0.001 that was highly significant. For loin pain there 
is 63.64% relief with p>0.05 that was insignificant. For 
the bodyache there was 12.5% relief with p<0.01 that 
was significant. 
Table 2: Effect of Shigru Ghana of  on haematological 



























































Lymphoc 31. 28 2.4 7.79 5.3 1.1 2. >0.


































The mean haemoglobin percentage decrease from 
11.07gm% to 10.94gm% which was statisticlly 
significant (P<0.01). Initial score in the total leukocyte 
count was 8100 which was decreased to 7105 was 
significant (P<0.001). There was an decreased 
observed in the mean neutrophil form 63.15 to 60.46  
which was significant (P>0.05). The initinal mean 
score of  lymphocytes was 31.46 which was decreased 
to 28 which was statistically signifcant (P>0.05).  
The ESR decreased from mean score of  48.05 to 31.5 
which was statistically significant (P<0.001). The mean 
score of S.cretanine was 1.00 which was decreased to 
0.94 after treatment which was significant. 






+++ 05 05 25 
++ 11 11 55 
+ 04 04 20 
The  sensitivy showed that 25% patients are high 
sensitive for Shigru Ghana while 55% were moderate 
sensitive and 20% were low sensitive for Shigru 
Ghana. 
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Urine  Culture  and  Sensitivity - The  observed  change  
was  70.46 %  with p<0.001 which is statistically highly 
significant. 
DISCUSSION 
The present research work has been carried out with 
a view to provide a scientific basis for the claims made 
in various Ayurvedic texts regarding the effect of 
Shigru Ghana. Shigru is having Katu (alkaline), Tikta in 
taste (Rasa). In Vipaka (post digestive effect) it is Katu 
and Ushna in Virya (potency) having Vata Kapha 
Nashaka property.[6] It has Laghu, Ruksha, Tikshna 
Guna. It is also Mutravirechaka in action.[7] 
It increases circulation of blood in kidney there by 
increases glomerular filtration rate and prevent Na+ 
(Sodium) reabsorpton in the urinary tubules which 
lead to increase amount of urine formation.[8] The 
Katu, Tikta Rasa are Krimighna (antimicrobial) as such 
it helps in treatment of E.coli. Ushna Virya has 
property opposite to Vata, i.e. Vasti, as such to help to 
cure diseses. It helps in the elimination of the bacteria 
out of the body due to its diuretic effect. Due to 
Laghu, Tikshna, Ruksha Guna it increases blood 
circulation in the kidney so that to eliminate bacteria. 
Sensitivity of Shigru shows that it has antibacterial 
activity.[9] 
CONCLUSION 
Having analysed the result on statistical parameters, it 
can be concluded that Shigru is highly effective for the 
treatment of Mutrakrichhra (Escherichia coli). The 
drugs are easily available so helpful in the treatment 
of urinary tract infection caused by Escherichia coli. 
The dose and duration of Shigru  can be increased to 
see the results in chronicity. There was no side effect 
observed in patients and so it is free from various 
drug hazards that occurs with other medicine. Shigru 
drug mentioned in almost all the ancient literature 
and has a bright future for the treatment of urinary 
tract infection caused by Escherichia coli. 
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